Longeveron Inc. (NASDAQ: LGVN) Stock Information | RedChip

Longeveron Inc. (NASDAQ: LGVN) Listen to this Section


$2.34
-0.1200 ( -4.88% ) 573.3K

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Market Data


Open


$2.34

Previous close


$2.46

Volume


573.3K

Market cap


$33.74M

Day range


$2.31 - $2.48

52 week range


$0.77 - $35.60

Insider Ownership Transactions

Total Amount Purchased: -20,426.00 | $ -47,796.84

Date Type Amount Purchased Purchaser
2024-04-12 Buy 106383.00 Hare Joshua
2024-03-20 Sale -80200.00 Hashad Mohamed Wa'el Ahmed
2024-02-02 Sale -50000.00 Hashad Mohamed Wa'el Ahmed
2024-01-25 Sale -4098.00 Locklear Lisa
2024-01-25 Sale -3074.00 Agafonova Nataliya
2024-01-25 Sale -5123.00 Hashad Mohamed Wa'el Ahmed
2024-01-25 Sale -992.00 Lehr Paul T
2024-01-11 Buy 5000.00 Ross Cathy
2024-01-02 Buy 1678.00 Baluch Khoso
2023-12-29 Buy 10000.00 PFEFFER JEFFREY

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jul 03, 2024
8-k 8K-related 18 Jun 18, 2024
4 Insider transactions 1 Jun 11, 2024
4 Insider transactions 1 Jun 07, 2024
ars Annual reports 1 May 20, 2024
def Proxies and info statements 4 May 20, 2024
10-q Quarterly Reports 72 May 14, 2024
3 Insider transactions 2 May 14, 2024
4 Insider transactions 1 May 14, 2024
8-k 8K-related 15 May 10, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.